| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 15, 2003
Accepted on November 25, 2003
1 Unité de Recherches sur l'Endocrinologie du Développement (INSERM), 32 rue des Carnets, 92140 Clamart, France; Biogen, Inc., 14 Cambridge Center, Cambridge MA 02142, USA
* To whom correspondence should be addressed. E-mail: Rich_Cate{at}Biogen.com.
Anti-Müllerian hormone (AMH), a transforming growth factor-
(TGF-
) family member, determines whether an individual develops a uterus and Fallopian tubes. Mutations in the AMH gene lead to persistent Müllerian duct syndrome (PMDS) in males. The wild type human AMH protein is synthesized as a disulfide-linked dimer of two identical 70 kDa polypeptides, which undergoes proteolytic processing to generate a 110 kDa N-terminal dimer and a bioactive 25 kDa TGF-
-like C-terminal dimer. We have studied the biosynthesis and secretion of wild type AMH and of seven PMDS proteins, containing mutations in either the N or C-terminal domain. Mutant proteins lacking the C-terminal domain are secreted more rapidly than full length AMH, while single amino acid changes in both domains can have profound effects on protein stability and folding. The addition of a cysteine in an N-terminal domain mutant, R194C, prevents proper folding, while the elimination of the cysteine involved in forming the interchain disulfide bond, in a C-terminal domain mutant, C525Y, leads to a truncation at the C-terminus. A molecular model of the AMH C-terminal domain provides insights into how some mutations could affect biosynthesis and function.
This article has been cited by other articles:
![]() |
M. E. Kevenaar, J. S. E. Laven, S. L. Fong, A. G. Uitterlinden, F. H. de Jong, A. P. N. Themmen, and J. A. Visser A Functional Anti-Mullerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1310 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Goglia, C. Toncini, M. Giusti, C. Gastaldi, C. Ambruosi, S. Sola, J.-L. Ravetti, G. Carmignani, F. Minuto, and D. Ferone A Unique Association of Clinical "Persistent Mullerian Duct Syndrome" and Syringoid Carcinoma of the Perineal-Scrotal Skin: A Consequence of Urologic Surgery? J Androl, January 1, 2008; 29(1): 15 - 19. [Full Text] [PDF] |
||||
![]() |
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. X. Liao, R. K. Moore, and S. Shimasaki Functional and Molecular Characterization of Naturally Occurring Mutations in the Oocyte-secreted Factors Bone Morphogenetic Protein-15 and Growth and Differentiation Factor-9 J. Biol. Chem., April 23, 2004; 279(17): 17391 - 17396. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |